Incidence of Gestational Diabetes Diagnosed on the 100-G Glucose Tolerance Test in Pregnancies with a 50-G Glucose Challenge Test Result of 200 mg/dL or Greater

Abstract

Objective This study aimed to assess the positive predictive value (PPV) of a 1-hour, 50-g glucose challenge test (GCT) result ≥200 mg/dL for the diagnosis of gestational diabetes mellitus (GDM) on a 3-hour, 100-g glucose tolerance test (GTT).

Study Design Pregnancies between 2008 and 2016 with a GCT result ≥200 mg/dL were identified retrospectively. GCT and GTT dates and results, demographics, and working due date (EDD) were extracted. Gestational age at testing was calculated from test date and EDD. As some clinicians presumptively diagnose GDM in such cases, if a GTT result was not available, clinic notes were reviewed to determine whether a GTT was ordered. Positive predictive values (PPV) were calculated at GCT cut-offs at and beyond 200 mg/dL. Subgroups were compared including early GCT (<16 weeks) versus routine GCT (24–28 weeks), GTT result normal versus GTT diagnostic of GDM, and GTT ordered versus GTT not ordered. Rates of use of medication for glycemic control were assessed among these groups.

Results Of 236 pregnant women with a GCT result ≥200 mg/dL, 115 (48%) GTT was ordered for 115 (49%), whereas 123 (52%) were managed as presumed GDM. Of 100 (87%) who completed the test, 81 (81%) were diagnosed with GDM with a median intertest interval of 14 days. No statistically significant differences were found between groups stratified by GTT result. Use of rates of metformin, glyburide, and insulin were similar between those diagnosed with GDM by GTT and those diagnosed with GDM by GCT alone.

Conclusion A GCT result of ≥200 mg/dL has a PPV of 81% for diagnosis of GDM by GTT in a contemporary U.S. population, with a median intertest interval of 14 days between GCT and GTT. However, those diagnosed by GCT alone were as likely as those diagnosed by GTT to require medication for glycemic control, including insulin, suggesting that requiring a GTT may result in underdiagnosis and delayed treatment of GDM.

Key Points

• A 50-g GCT result of 200 mg/dL or greater has a PPV of 81% for GDM on the 100 g GTT.

• Patients diagnosed with GDM by GCT alone were as likely to require insulin as those diagnosed by GTT.

• 81% of patients diagnosed with GDM on the GTT completed their GTT at least 1 week after the GCT, thus requiring GTT in this population may lead to unnecessary delays in care.

Keywords

gestational diabetes - diabetes screening - elevated 50-g diabetes screen - glucola over 200

Note

This project was presented as a podium presentation at the following meetings:

2017 ACOG Virginia Section Meeting; 2017 September 8; Richmond, VA.

2017 ACOG District I and IV Joint Meeting; 2017 October 6–8; Charlotte, NC.

Publikationsverlauf

Eingereicht: 08. Februar 2021

Angenommen: 03. Juni 2022

Accepted Manuscript online:
16. Juni 2022

Artikel online veröffentlicht:
23. August 2022

• References

• 1 Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005; 192 (04) 989-997
• 2 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
• 3 Langer O, Berkus M, Brustman L, Anyaegbunam A, Mazze R. Rationale for insulin management in gestational diabetes mellitus. Diabetes 1991; 40 (Suppl. 02) 186-190
• 4 Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus–how tight is tight enough: small for gestational age versus large for gestational age?. Am J Obstet Gynecol 1989; 161 (03) 646-653
• 5 Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
• 6 Wong VW, Garden F, Jalaludin B. Hyperglycaemia following glucose challenge test during pregnancy: when can a screening test become diagnostic?. Diabetes Res Clin Pract 2009; 83 (03) 394-396
• 7 Shrestha A, Chawla CD. The glucose challenge test for screening of gestational diabetes. Kathmandu Univ Med J (KUMJ) 2011; 9 (34) 22-25
• 8 Adegbola O, Ajayi GO. Screening for gestational diabetes mellitus in Nigerian pregnant women using fifty-gram oral glucose challenge test. West Afr J Med 2008; 27 (03) 139-143
• 9 Keshavarz M, Cheung NW, Babaee GR. The value of the screening test for gestational diabetes in pregnant Iranian women. Diabetes Res Clin Pract 2006; 73 (01) 98-99
• 10 Jirapinyo M, Puavilai G, Chanprasertyotin S, Tangtrakul S. Predictive value of 1 hour 50 g oral glucose load screening test for gestational diabetes mellitus compared to 3 hour oral glucose tolerance test in high risk pregnant women. Asia Oceania J Obstet Gynaecol 1993; 19 (01) 7-12
• 11 Bolaños R, Ambás M, Zea F, Herrerías T, Barranco A. Analysis of the 50g glucose test at the National Institute of Perinatology [in Spanish]. Ginecol Obstet Mex 1997; 65: 52-55
• 12 Ardawi MS, Nasrat HA, Jamal HS, Al-Sagaaf HM, Mustafa BE. Screening for gestational diabetes mellitus in pregnant females. Saudi Med J 2000; 21 (02) 155-160
• 13 Chua S, Thai AC, Kek LP, Yeoh SC, Ratnam SS. The glucose challenge test: a screening test for gestational diabetes mellitus. Singapore Med J 1993; 34 (04) 303-305
• 14 Mazze R, Strock ES, Simonson GD, Bergenstal RM. Staged Diabetes Management: A Systematic Approach. West Sussex, England: John Wiley & Sons; 2007